Home » Archive

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

News, Syndication »

Big Late-Stage Deals and Unicorns Drive U.S. Venture Activity Higher

Posted by sandiegobiotech July 10th, 2014 .
No Comments

Two years ago, VC firms shrugged off sluggish economic conditions to invest $8.1 billion in 812 U.S. deals in the second quarter. It was the highest total in more than a decade—and represented…

[[Click headline to continue reading.]]

More...

News, Syndication »

Charles E. Daniels to be Honored for His Leadership in Health-System Pharmacy

Posted by sandiegobiotech July 9th, 2014 .
No Comments

The American Society of Health-System Pharmacists (ASHP) has named Charles E. Daniels, PhD, FASHP, as the recipient of the 2014 John W. Webb Lecture Award. The Webb Award honors health-system pharmacy practitioners or educators who stand…

More...

News, Syndication »

Stem cell boss joins board he funded

Posted by sandiegobiotech July 9th, 2014 .
No Comments

One week after leaving, former CIRM president Alan Trounson joins agency-funded company.

More...

News, Syndication »

Scripps Research kills takeover by USC

Posted by sandiegobiotech July 9th, 2014 .
No Comments

Faculty opposition leads board to scuttle deal with University of Southern California.

More...

News, Syndication, Xconomy »

Brazil: Ready for Future Growth in Health Care

Posted by sandiegobiotech July 9th, 2014 .
No Comments

The eyes of the world are on Brazil. It is one of the most dynamic countries in the southern hemisphere; the sixth-largest economy in the world; and host of the World Cup, now drawing to a close. In…

[[Click headline to continue reading.]]

More...

News, Syndication »

No extra mutations in modified stem cells, study finds

Posted by sandiegobiotech July 8th, 2014 .
No Comments

LA JOLLA—The ability to switch out one gene for another in a line of living stem cells has only crossed from science fiction to reality within this decade. As with any new technology, it brings with it both promise—the hope of fixing disease-causing genes in humans, for example—as well as questions and safety concerns. Now, Salk scientists have put one of those concerns to rest: using gene-editing techniques on stem cells doesn’t increase the overall occurrence of mutations in the cells. The new results were published July 3 in the journal Cell Stem Cell.

More...

News, Syndication »

Beetham Appointed CEO at Cibus

Posted by sandiegobiotech July 8th, 2014 .
No Comments

Peter Beetham has taken the CEO’s job at Cibus, the Mira Mesa-based biotech announced July 8.

More...

News, Syndication »

Oh Canada! Versant’s Strategic Shifts Lead to $300M Fund

Posted by sandiegobiotech July 8th, 2014 .
No Comments

Versant Ventures, based in the San Francisco Bay Area but growing in Europe and especially Canada, is a few million dollars away from closing a new US$300 million fund, according to a regulatory…

[[Click headline to continue reading.]]

More...

News, Syndication »

Arena slumps after CEO sells shares

Posted by sandiegobiotech July 7th, 2014 .
No Comments

Belviq maker drops 9.4 percent Monday, the first trading day since July 3.

More...

News, Syndication »

Study finds new path to treat Alzheimer’s, stroke

Posted by sandiegobiotech July 7th, 2014 .
No Comments

Switch activated by nitric oxide causes neuron death, blocking it possible.

More...